Table 1.
Baseline demographics and clinical characteristics of 1 year survivors versus non-survivors.
| Variable | Survivors (N = 11) |
Non-survivors (N = 20) |
p-value |
|---|---|---|---|
|
| |||
| Age (IQR) | 63 (50, 69) | 67 (60, 75) | 0.11 |
|
| |||
| Race, n (%) | |||
| Caucasian | 7 (64) | 18 (90) | 0.08 |
| African American | 4 (36) | 2 (10) | 0.08 |
|
| |||
| Male, n (%) | 10 (90) | 11 (55) | 0.04 |
|
| |||
| Comorbidities, n (%) | |||
| Coronary artery disease | 3 (27) | 4 (20) | 0.64 |
| Cerebrovascular accident | 3 (27) | 1 (5) | 0.08 |
| Hypertension | 8 (73) | 14 (70) | 0.87 |
| Insulin dependent diabetes | 2 (18) | 3 (15) | 0.82 |
| Non-insulin dependent diabetes | 2 (18) | 4 (20) | 0.90 |
| Chronic Renal Insufficiency | 3 (27) | 3 (15) | 0.41 |
| Malignancy | 1 (9) | 4 (20) | 0.43 |
|
| |||
| SOFA score (IQR) | 14 (8, 14) | 11.5 (10, 14) | 0.95 |
SOFA - Sequential Organ Failure Assessment Score; IQR – interquartile range